Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30044744HIVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS30044745HIVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS30044746HIVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS30044747HIVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS20012691HPVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS20065630HPVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS20041200HPVENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS44035536HTLV-1ENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS44051390HTLV-1ENSG00000178607.17protein_codingERN1NoNo2081O75460
TVIS44051391HTLV-1ENSG00000178607.17protein_codingERN1NoNo2081O75460
TCGA Plot Options
Drug Information
GeneERN1
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0003839
UniProt IDO75460
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830